Therapeutic Agents in Acne Vulgaris: Part II. D-Alpha Amino Benzyl Penicillin, Erythromycin and Sulfadimethoxine

Therapeutic Agents in Acne Vulgaris: Part II. D-Alpha Amino Benzyl Penicillin, Erythromycin and Sulfadimethoxine

A total of 379 patients with pustular and cystic acne vulgaris were selected for study in three groups. Each group was assigned one of the following medications: benzyl penicillin, erythromycin, sulfadimethoxine, or placebo; these were to be compared with tetracycline, a medication whose effectivene...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian Medical Association journal 1965-06, Vol.92 (26), p.1339-1341
Hauptverfasser: Stewart, W D, Maddin, S, Nelson, A J, Danto, J L
Format: Artikel
Sprache:eng
Schlagworte:
Original
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1341
container_issue 26
container_start_page 1339
container_title Canadian Medical Association journal
container_volume 92
creator Stewart, W D
Maddin, S
Nelson, A J
Danto, J L
description A total of 379 patients with pustular and cystic acne vulgaris were selected for study in three groups. Each group was assigned one of the following medications: benzyl penicillin, erythromycin, sulfadimethoxine, or placebo; these were to be compared with tetracycline, a medication whose effectiveness was previously demonstrated in this type of acne. The study revealed a larger number of favourable responses to tetracycline and erythromycin than to sulfadimethoxine. Sulfadimethoxine, however, produced a greater number of favourable responses than did the benzyl penicillin or the placebo; the last-named had equivalent results.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1928621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733419157</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1101-cc2fdc9a5c14ca6fc9bdbe7d151844fda502b02a1a1548b0d9f705544fd225a43</originalsourceid><addsrcrecordid>eNpVkEFLwzAcxXtQ3Jx-BcnNi5UkTdbWg1B16mDgwOm1_JukayRNa9KK9dNbcYqe3uE9fo_39oIpxjgJGcPpJDj0_gVjGlHMDoIJxRFN6JxOg3ZTKQet6jstULZVtvNIW5QJq9Bzb7bgtL9Aa3AdWi7P0U2YmbYClNXaNuhK2Y_BoLWyWmhjtD1DCzd0lWvqQYwUsBI99qYEqWvVVc27tuoo2C_BeHW801nwdLvYXN-Hq4e75XW2CltCMAmFoKUUKXBBmIB5KdJCFiqWhJOEsVICx7TAFAgQzpICy7SMMedfFqUcWDQLLr-5bV_USopxmQOTt07X4Ia8AZ3_d6yu8m3zlpOUJnNKRsDpDuCa1175Lq-1F8oYsKrpfR5HESMp4fGYPPlb9dvx83L0CY26ed4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733419157</pqid></control><display><type>article</type><title>Therapeutic Agents in Acne Vulgaris: Part II. D-Alpha Amino Benzyl Penicillin, Erythromycin and Sulfadimethoxine</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Stewart, W D ; Maddin, S ; Nelson, A J ; Danto, J L</creator><creatorcontrib>Stewart, W D ; Maddin, S ; Nelson, A J ; Danto, J L</creatorcontrib><description>A total of 379 patients with pustular and cystic acne vulgaris were selected for study in three groups. Each group was assigned one of the following medications: benzyl penicillin, erythromycin, sulfadimethoxine, or placebo; these were to be compared with tetracycline, a medication whose effectiveness was previously demonstrated in this type of acne. The study revealed a larger number of favourable responses to tetracycline and erythromycin than to sulfadimethoxine. Sulfadimethoxine, however, produced a greater number of favourable responses than did the benzyl penicillin or the placebo; the last-named had equivalent results.</description><identifier>ISSN: 0008-4409</identifier><identifier>PMID: 20328262</identifier><language>eng</language><publisher>Canada</publisher><subject>Original</subject><ispartof>Canadian Medical Association journal, 1965-06, Vol.92 (26), p.1339-1341</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1928621/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1928621/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,53793,53795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20328262$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stewart, W D</creatorcontrib><creatorcontrib>Maddin, S</creatorcontrib><creatorcontrib>Nelson, A J</creatorcontrib><creatorcontrib>Danto, J L</creatorcontrib><title>Therapeutic Agents in Acne Vulgaris: Part II. D-Alpha Amino Benzyl Penicillin, Erythromycin and Sulfadimethoxine</title><title>Canadian Medical Association journal</title><addtitle>Can Med Assoc J</addtitle><description>A total of 379 patients with pustular and cystic acne vulgaris were selected for study in three groups. Each group was assigned one of the following medications: benzyl penicillin, erythromycin, sulfadimethoxine, or placebo; these were to be compared with tetracycline, a medication whose effectiveness was previously demonstrated in this type of acne. The study revealed a larger number of favourable responses to tetracycline and erythromycin than to sulfadimethoxine. Sulfadimethoxine, however, produced a greater number of favourable responses than did the benzyl penicillin or the placebo; the last-named had equivalent results.</description><subject>Original</subject><issn>0008-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1965</creationdate><recordtype>article</recordtype><recordid>eNpVkEFLwzAcxXtQ3Jx-BcnNi5UkTdbWg1B16mDgwOm1_JukayRNa9KK9dNbcYqe3uE9fo_39oIpxjgJGcPpJDj0_gVjGlHMDoIJxRFN6JxOg3ZTKQet6jstULZVtvNIW5QJq9Bzb7bgtL9Aa3AdWi7P0U2YmbYClNXaNuhK2Y_BoLWyWmhjtD1DCzd0lWvqQYwUsBI99qYEqWvVVc27tuoo2C_BeHW801nwdLvYXN-Hq4e75XW2CltCMAmFoKUUKXBBmIB5KdJCFiqWhJOEsVICx7TAFAgQzpICy7SMMedfFqUcWDQLLr-5bV_USopxmQOTt07X4Ia8AZ3_d6yu8m3zlpOUJnNKRsDpDuCa1175Lq-1F8oYsKrpfR5HESMp4fGYPPlb9dvx83L0CY26ed4</recordid><startdate>19650626</startdate><enddate>19650626</enddate><creator>Stewart, W D</creator><creator>Maddin, S</creator><creator>Nelson, A J</creator><creator>Danto, J L</creator><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19650626</creationdate><title>Therapeutic Agents in Acne Vulgaris: Part II. D-Alpha Amino Benzyl Penicillin, Erythromycin and Sulfadimethoxine</title><author>Stewart, W D ; Maddin, S ; Nelson, A J ; Danto, J L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1101-cc2fdc9a5c14ca6fc9bdbe7d151844fda502b02a1a1548b0d9f705544fd225a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1965</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Stewart, W D</creatorcontrib><creatorcontrib>Maddin, S</creatorcontrib><creatorcontrib>Nelson, A J</creatorcontrib><creatorcontrib>Danto, J L</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stewart, W D</au><au>Maddin, S</au><au>Nelson, A J</au><au>Danto, J L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Agents in Acne Vulgaris: Part II. D-Alpha Amino Benzyl Penicillin, Erythromycin and Sulfadimethoxine</atitle><jtitle>Canadian Medical Association journal</jtitle><addtitle>Can Med Assoc J</addtitle><date>1965-06-26</date><risdate>1965</risdate><volume>92</volume><issue>26</issue><spage>1339</spage><epage>1341</epage><pages>1339-1341</pages><issn>0008-4409</issn><abstract>A total of 379 patients with pustular and cystic acne vulgaris were selected for study in three groups. Each group was assigned one of the following medications: benzyl penicillin, erythromycin, sulfadimethoxine, or placebo; these were to be compared with tetracycline, a medication whose effectiveness was previously demonstrated in this type of acne. The study revealed a larger number of favourable responses to tetracycline and erythromycin than to sulfadimethoxine. Sulfadimethoxine, however, produced a greater number of favourable responses than did the benzyl penicillin or the placebo; the last-named had equivalent results.</abstract><cop>Canada</cop><pmid>20328262</pmid><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-4409
ispartof Canadian Medical Association journal, 1965-06, Vol.92 (26), p.1339-1341
issn 0008-4409
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1928621
source PubMed Central; Alma/SFX Local Collection
subjects Original
title Therapeutic Agents in Acne Vulgaris: Part II. D-Alpha Amino Benzyl Penicillin, Erythromycin and Sulfadimethoxine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T06%3A15%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Agents%20in%20Acne%20Vulgaris:%20Part%20II.%20D-Alpha%20Amino%20Benzyl%20Penicillin,%20Erythromycin%20and%20Sulfadimethoxine&rft.jtitle=Canadian%20Medical%20Association%20journal&rft.au=Stewart,%20W%20D&rft.date=1965-06-26&rft.volume=92&rft.issue=26&rft.spage=1339&rft.epage=1341&rft.pages=1339-1341&rft.issn=0008-4409&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E733419157%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733419157&rft_id=info:pmid/20328262&rfr_iscdi=true